A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study
ConclusionSwitching from insulin to IDegAsp co-formulation was associated with significantly improved glycemic control and a reduction in hypoglycemia rate during 12 months of follow-up in Japanese patients with T2D, including those aged > 75 years.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Databases & Libraries | Diabetes | Drugs & Pharmacology | Endocrinology | Insulin | Japan Health | Study